Skip to main content
OpenTrials

Clinical trial condition

Parkinson Disease

Explore clinical trials studying Parkinson Disease. Study availability and eligibility vary by location and protocol.

1,814 public trials 369 recruiting studies
Refine in advanced search Browse all conditions

Parkinson Disease trial results

Completed

Training and Parkinson's

NCT03434327

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Max Orovitz Laboratories Coral Gables, Florida, United States
View Trial Details
Completed

FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)

NCT03170063

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Oregon Health and Sciences University Portland, Oregon, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528

NCT01536574

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Wuhan, Hubei, China
  • GSK Investigational Site Suzhou, Jiangsu, China
  • GSK Investigational Site Xi'an, Shaanxi, China
View all 18 locations
View Trial Details
Completed

A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa

NCT01154166

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Wuhan, Hubei, China
  • GSK Investigational Site Suzhou, Jiangsu, China
  • GSK Investigational Site Xi'an, Shaanxi, China
View all 18 locations
View Trial Details

Related conditions